Featured

Civica to Launch Affordable Long-Acting Insulin Glargine in the US

Non-profit pharmaceutical company Civica is set to launch a long-acting insulin, insulin glargine-yfgn, in pre-filled pens at the lowest list price in...

Home/KnolSights/Regulatory Approvals/Civica to Launch Affordable Long-Acting Insulin Glargine in the US